Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06379581

Skin Cancer Diagnostics Using Photoacoustic Imaging

Photoacoustic Imaging for Three-dimensional Delineation of Skin Tumors

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In this clinical study, photoacoustic imaging will be used on patients with suspected skin cancer (primarily melanoma, basal cell carcinoma, and squamous cell carcinoma) to determine the tumor borders both superficially and at a depth.

Detailed description

The study will employ multispectral photoacoustic imaging in the spectral range between 680-970 nm to scan suspected skin tumors both in vivo and ex vivo. The hyperspectral data will then undergo rigorous spectral analysis with the objective to identify the spectral fingerprints associated with healthy tissue and tumor. Thereafter, a classification algorithm will be used to determine whether a pixel in the acquired image more likely identifies with healthy tissue or tumor, which is then repeated for all pixels in the images. As such, a 3D image can be reconstructed in which the tumor is visibly contrasted from healthy tissue. Achieving this goal will facilitate the diagnostic procedures and greatly reduce waiting times, clinical costs and potential patient suffering.

Conditions

Timeline

Start date
2023-01-01
Primary completion
2025-10-01
Completion
2025-10-01
First posted
2024-04-23
Last updated
2024-04-24

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06379581. Inclusion in this directory is not an endorsement.